EP3092252

ANTIBODY TARGETING CELL SURFACE DEPOSITED COMPLEMENT PROTEIN C3D AND USE THEREOF

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    8.1.2015
  • EP published:
    18.9.2019
  • EP application number:
    15701442.4
  • Max expiry date:
    7.1.2035
  • Title:
    ANTIBODY TARGETING CELL SURFACE DEPOSITED COMPLEMENT PROTEIN C3D AND USE THEREOF

Timeline

Today
8.1.2015EP application
18.9.2019EP Publication

Owner

  • Name:
    The U.S.A. as represented by the Secretary, Department of Health and Human Services
  • Address:
    Office of Technology Transfer National Institutes of Health 6011 Executive Boulevard, Suite 325 MSC 7660, 20892-7660, Bethesda, MD, US
  • Name:
    University of Virginia Patent Foundation d/b/a University of Virginia Licensing & Ventures Group
  • Address:
    250 West Main Street, Suite 300, 22902, Charlottesville, VA, US

Inventor

  • Name:
    WIESTNER, Adrian U.
  • Address:
    Bethesda, Maryland, US
  • Name:
    SKARZYNSKI, Martin W.
  • Address:
    North Bethesda, Maryland, US
  • Name:
    LINDORFER, Margaret A.
  • Address:
    Keswick, Virginia, US
  • Name:
    TAYLOR, Ronald P.
  • Address:
    Keswick, Virginia, US
  • Name:
    RADER, Christoph
  • Address:
    Jupiter, Florida, US
  • Name:
    VIRE, Bérengère
  • Address:
    Les Matelles, FR

Priority

  • Number:
    201461924967 P
  • Date:
    8.1.2014
  • Country:
    US

Classification

  • Categories:
    C07K 16/18, C07K 16/30, A61P 35/02, C07K 14/725, C07K 14/47, A61K 39/00

Upload documents